Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Inspire Medical Systems, Inc. (INSP)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
223.54+11.69 (+5.52%)
At close: 04:00PM EDT
223.54 +0.09 (+0.04%)
After hours: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close211.85
Open216.90
Bid215.18 x 800
Ask231.16 x 800
Day's Range214.22 - 223.57
52 Week Range142.74 - 286.29
Volume190,634
Avg. Volume261,091
Market Cap6.178B
Beta (5Y Monthly)1.54
PE Ratio (TTM)N/A
EPS (TTM)-1.55
Earnings DateOct 31, 2022 - Nov 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est282.78
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for INSP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Inspire Medical Systems, Inc.
    Analyst Report: VeriSign, Inc.Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world’s 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
    Rating
    Fair Value
    Economic Moat
    13 days agoMorningstar
View more
  • Zacks

    Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates

    Inspire (INSP) delivered earnings and revenue surprises of 10.17% and 15.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Inspire Medical Systems, Inc. Announces Second Quarter 2022 Financial Results and Updates 2022 Outlook

    Inspire Reports Year-over-Year Revenue Growth of 73% in the Second QuarterMINNEAPOLIS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended June 30, 2022. Recent Business Highlights Generated revenue of $91.4 million in the second quarter of 202

  • GlobeNewswire

    Inspire Medical Systems, Inc. Announces Appointment of Two New Independent Directors to its Board

    Company adds further expertise in human capital strategy and medical device industry R&D, regulatory affairs and commercializationMINNEAPOLIS, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced the appointments of Cynthia Burks and Charisse Sparks, M.D., as independent directors to

Advertisement
Advertisement